Evidence map›Paper›PMID 30087744›Full record

ArticleOpen access Macedonian journal of medical sciences2018

On the Epidemiology and Statistical Analysis of HIV/AIDS Patients in the Insurgency Affected States of Nigeria.

Patience I Adamu, Pelumi E Oguntunde, Hilary I Okagbue, Olasunmbo O Agboola

Abstract read
In one paragraph

Article in Open access Macedonian journal of medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. [Research progress on occupational exposure and protection from acquired immunodeficiency syndrome in stomatological departments].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2019
    Article
  6. Article
  7. Hepatitis E Infection in Nigeria: A Systematic Review.Open access Macedonian journal of medical sciences · 2019
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Patience I AdamuDepartment of Mathematics, Covenant University, Ota, Nigeria.
Pelumi E OguntundeDepartment of Mathematics, Covenant University, Ota, Nigeria.
Hilary I OkagbueDepartment of Mathematics, Covenant University, Ota, Nigeria.
Olasunmbo O AgboolaDepartment of Mathematics, Covenant University, Ota, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe effect of insurgencies on a nation regarding the economy, education, health and infrastructure cannot be overemphasised.

aimThis research is therefore focused on analysing the incidence of HIV/AIDS disease in states affected by the activities of the Boko Haram insurgency in Nigeria. MATERIAL AND

methodsThe data collected refer to the period from 2004 to 2017, reporting information on 16,102 patients and including the age, gender, year of diagnosing and status of the patients. Descriptive, Chi-square test of independence and Correlation analyses were performed using Statistical Package for Social Sciences (SPSS) version 20.

resultsIt was discovered that the majority of those living with HIV/AIDS in these Boko Haram ravaged areas are females between the age group of 30 years to 39 years. Reported cases of HIV/AIDS started increasing significantly from age 20, and the highest number of reported cases of HIV/AIDS was recorded in the year 2017.

conclusionThe status of the patient was found to be dependent on both the gender and age of the patients' treatment, though the strength of the linear relationship between status and age is not significantly different from zero.

Indexed as

AIDSBoko HaramEpidemiologyHIVNigeria

Identifiers

PMID30087744
PMCPMC6062286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.